Intezyne Technologies Employee Directory
Biotechnology ResearchFlorida, United States2-10 Employees
Intezyne Technologies is a clinical-stage biotechnology company focused on improving the effectiveness of cancer treatments through a portfolio of proprietary assets and advancing them through clinical development. It operates in the biotechnology research industry and is based in Tampa, Florida, with a small team of 2 to 10 employees. The company is developing novel anti-cancer therapies, including IT-139, a Cancer Resistance Pathway inhibitor intended for use in combination with existing therapies across pancreatic, gastric, and other cancers. Intezyne has engaged in partnerships and financing, including a collaboration with Exosome Diagnostics to design and validate an assay for use in upcoming Phase 1/2 trials and a Series A financing in 2017 led by Gaston Capital Healthcare Fund. Corporate governance has included Gaston Capital representatives joining the board as part of the financing, and the company maintains a website at intezyne.com.